Efficacy of Using NLR and IL-6 as Outcome Predictors of HCC
Hepatocellular carcinoma (HCC) is currently the fifth most common solid tumor worldwide and the third leading cause of cancer-related death. Percutaneous ethanol injection (PEI) and radio frequency ablation (RFA) techniques became well-known procedures for controlling small HCC. Inflammation is a major contributing factor to carcinogenesis specially HCC. Inflammatory mediators including interleukin- 6 (IL-6) and neutrophil to lymphocyte ratio (NLR) are good candidates to stimulate tumor growth and progression.
Download Efficacy of Using NLR and IL-6 as Outcome Predictors of HCC (9783659870095).pdf, available at pdfstock.com for free.
- Ahmed Mohamed El Gebaly
- Paperback | 188 pages
- 150 x 220 x 11mm | 296g
- Publication date
- 03 May 2016
- LAP Lambert Academic Publishing